SCHEMBL16013197

SCHEMBL16013197

C#CCCCC(=O)OCC(C)(COC(=O)CCCC#C)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.39
CYP1A2 P05177 3/20 0.39
CYP2C19 P33261 2/20 0.39
MAPT P10636 2/20 0.39
CYP2C9 P11712 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP3A4 P08684 2/20 0.37
ALOX5 P09917 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
CNR1 P21554 2/20 0.35
CNR2 P34972 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
GSTP1 P09211 1/20 0.33
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
PAM P19021 2/20 0.32
TSHR P16473 2/20 0.32
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17411125 0.93 CYP1A2 (0.44) CYP2D6CYP1A2CYP2C19MAPTCYP2C9
SCHEMBL17404814 0.88 CYP1A2 (0.31) CYP2D6CYP1A2CYP2C19MAPTCYP2C9
SCHEMBL27445171 0.84 ALOX5 (0.40) CYP2D6CYP1A2CYP2C19MAPTCYP2C9
SCHEMBL20502641 0.80 CNR1 (0.38) CYP2D6CYP1A2CYP2C19MAPTCYP2C9
SCHEMBL21916203 0.78 CNR1 (0.35) ALOX5PTGS1PTGS2CNR1CNR2
SCHEMBL15466818 0.78 ALOX5 (0.35) CYP2D6CYP1A2CYP2C19MAPTCYP2C9
SCHEMBL24916787 0.77 CYP1A2 (0.38) CYP2D6CYP1A2CYP2C19MAPTCYP2C9
SCHEMBL25976495 0.76 CNR1 (0.34) CYP2D6CYP1A2CYP2C19MAPTCYP2C9
SCHEMBL14438152 0.76 GPR84 (0.42) MAPTKDM4EPAMTSHRMEN1
SCHEMBL8665617 0.76 DGKA (0.58) MAPTHSD17B10ALDH1A1KDM4EPAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12503553-B2 Biodegradable drug-polymer conjugate POLYACTIVA PTY LTD (AU) 2025-12-23 US disclosed
US-20240247106-A1 BIODEGRADABLE DRUG-POLYMER CONJUGATE POLYACTIVA PTY LTD (AU) 2024-07-25 US disclosed
EP-2964224-B1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT POLYACTIVA PTY LTD (AU) 2024-07-03 EP disclosed
EP-2964224-B1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT POLYACTIVA PTY LTD (AU) 2024-07-03 EP disclosed
US-11787906-B2 Biodegradable drug-polymer conjugate POLYACTIVA PTY LTD (AU) 2023-10-17 US disclosed
US-11787906-B2 Biodegradable drug-polymer conjugate POLYACTIVA PTY LTD (AU) 2023-10-17 US disclosed
US-20220401455-A1 BIODEGRADABLE DRUG-POLYMER CONJUGATE POLYACTIVA PTY LTD (AU) 2022-12-22 US disclosed
WO-2021051149-A1 BIODEGRADABLE DRUG-POLYMER CONJUGATE POLYACTIVA PTY LTD (AU) 2021-03-25 WO disclosed
WO-2021051149-A1 BIODEGRADABLE DRUG-POLYMER CONJUGATE POLYACTIVA PTY LTD (AU) 2021-03-25 WO disclosed
US-20200123322-A1 BIODEGRADABLE DRUG-POLYMER CONJUGATE POLYACTIVA PTY LTD (AU) 2020-04-23 US disclosed
US-20170182173-A1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT POLYACTIVA PTY LTD (AU) 2017-06-29 US disclosed
US-20170182173-A1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT POLYACTIVA PTY LTD (AU) 2017-06-29 US disclosed
US-9572892-B2 Polymer conjugate for delivery of a bioactive agent POLYACTIVA PTY LTD (AU) 2017-02-21 US disclosed
US-9572892-B2 Polymer conjugate for delivery of a bioactive agent POLYACTIVA PTY LTD (AU) 2017-02-21 US disclosed
US-9572892-B2 Polymer conjugate for delivery of a bioactive agent POLYACTIVA PTY LTD (AU) 2017-02-21 US disclosed
EP-2964224-A1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT Polyactiva Pty Ltd (AU) 2016-01-13 EP disclosed
US-20160000929-A1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT POLYACTIVA PTY LTD (AU) 2016-01-07 US disclosed
US-20160000929-A1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT POLYACTIVA PTY LTD (AU) 2016-01-07 US disclosed
US-20160000929-A1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT POLYACTIVA PTY LTD (AU) 2016-01-07 US disclosed
WO-2014134689-A1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT POLYACTIVA PTY LTD (AU) 2014-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240247106-A1 BIODEGRADABLE DRUG-POLYMER CONJUGATE ADRB3, PTGER3, CHRNE CYP2D6 96/4885CYP1A2 101/4885CYP2C19 62/4885
US-20200123322-A1 BIODEGRADABLE DRUG-POLYMER CONJUGATE ADRB3, PTGER3, CHRNE CYP2D6 96/4885CYP1A2 101/4885CYP2C19 62/4885
US-20220401455-A1 BIODEGRADABLE DRUG-POLYMER CONJUGATE PTGER1, PTGDR, F12 CYP2D6 68/4885CYP1A2 23/4885CYP2C19 24/4885
US-20160000929-A1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT PTGIS, PTGIR, PGF CYP2D6 2458/4885CYP1A2 1282/4885CYP2C19 346/4885
US-20170182173-A1 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT PTGIS, PTGIR, PGF CYP2D6 2985/4885CYP1A2 1386/4885CYP2C19 650/4885
US-11787906-B2 Biodegradable drug-polymer conjugate ADRB3, PTGER3, CHRM3 CYP2D6 102/4885CYP1A2 94/4885CYP2C19 58/4885
US-12503553-B2 Biodegradable drug-polymer conjugate ADRB3, PTGER3, CHRNE CYP2D6 96/4885CYP1A2 101/4885CYP2C19 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.